Transgenic mice ubiquitously expressing human Fas ligand develop a slight form of graft-versus-host-like disease

Acta Pharmacologica Sinica

Volumn 22, Issue 4, 2001, Pages 311-319

  Ma, Y H ^a   Fei, J ^a   Hu, J H ^a   Zhou, X E ^a   Xia, G H ^a   Guo, L H ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Antisense DNA; Fas ligand; Flow cytometry; Fluorescent antibody technique; Graft vs Host disease; Reverse transcriptase polymerase chain reaction; Transgenic mice

Indexed keywords

CD3 ANTIGEN; CYCLOSPORIN A; FAS LIGAND; RETINOID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; FLOW CYTOMETRY; GENOTYPE; GRAFT VERSUS HOST REACTION; IMMUNOFLUORESCENCE; LIGAND BINDING; MOLECULAR INTERACTION; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SPLEEN CELL;

ANIMALS; DNA, COMPLEMENTARY; FAS LIGAND PROTEIN; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RNA, MESSENGER;

EID: 0035053945     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Expression of Fas ligand in cells of T cell lineage
2. Fas-mediated cytotoxicity by freshly isolated natural killer cells
3. Activated B cells express functional Fas ligand
4. T cell receptor induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A
5. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid x receptors and retinoic acid receptors
6. TCR/CD3 coupling to Fas-based cytotoxicity
7. 2+-independent T cell-mediated cytotoxicity
8. + thymocyte population associated with intact Fas antigen expression on the target
9. Activation-induced death of mature T cells in regulation of immune responses
10. Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity
11. Fas and Fas ligand: lpr and gld mutations
12. Fas ligand in human serum
13. Fas ligand-mediated killing by intestinal graft-versus-host disease
14. Increased soluble Fas-ligand in sera of born morrow transplant recipients with acute graft-versus-host disease
15. Transcriptional activation of CYP2C, MxA and Fas in sudden infant death syndrome
16. Fas ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10
17. Upregulation of Fas/Fas ligand in inclusion body myositis
18. Apoptosis-associated proteins P53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome
19. Apoptosis and ageing
20. Fas ligand-induced apoptosis as a mechanism of immune privilege
21. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
22. Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival
23. Lymphocyte apoptosis induced by CD95 (APO-1/ Fas) ligand-expressing tumor cells - A mechanism of immune evasion?
24. A role for CD95 ligand in preventing graft rejection
25. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice
26. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction
27. Human Fas ligand: Gene structure, chromosomal location and species specificity
28. Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain?
29. The enhancer domain promoter determines cell type-specific expression in transgenic mice
30. Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies
31. Not so Fas: Re-evaluation the mechanisms of immune privilege and tumor escape
32. Increased lymphocyte apoptosis in Fas ligand transgenic mice
33. Cytotoxic T cells deficient in both fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease
34. Massive up-regulation of the Fas ligand in lpr and gld mice: Implications for Fas regulation and the graft-versus-host disease-like Wasting syndrome
35. IL-18 accounts for both TNF-alpha and Fas ligand mediated hepatotoxicity pathways in endotoxin-induced liver injury in mice
36. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression
37. Transgenic expression of Cd95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet al lografts
38. Immune response and myoblasts that express Fas ligand
39. Rejection of Fas ligand-expressing grafts
40. Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection
41. Accelerated rejection of Fas ligand-expressing heart grafts
42. Endothelial expression of Fas ligand in transgenic rats under the temporal control of a tetracycline-inducible system
43. Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis